Blood Plasma Products Market (2018-2023)| CSL Behring, Shire Plc, Grifols S.A., Octapharma AG, ADMA Biologics

The global blood plasma products market is forecasted to grow at a CAGR of 6.8% and will reach USD 28.5 Bn in 2023 from USD 20.5 Bn in 2018. The increasing demand of immunoglobulin for the treatment of immunodeficiency drive the market growth. The blood plasma products market is segmented based on product types like immunoglobulin, albumin, hyperimmune globulin, coagulation factor VIII, coagulation factor IX, and other plasma products. The market is also segmented based on end users such as hospitals, clinics, and other end users. Rise in technology at plasma collection centers to collect plasma and record patient history, and use of dried plasma that reduced cold chBlood Plasma Productsn requirements are the major trends in the market that may boost the market growth.

Get Sample Copy: https://www.worldwidemarketreports.com/sample/273936

Segmentation based on product types

Based on product types, immunoglobulin market has the highest market share (approximately 47%) because of the growing incidence of immunological diseases coupled with the rise in the geriatric population. The market share of albumin was 15.6% in 2018 which is driven by the rise in adoption of albumin in developing countries and an increase in awareness of recombinant albumin but post-operative risks associated with albumin-based therapy may hamper the market growth. Albumin market share is followed by hyperimmune globulin, coagulation factor VIII, and coagulation factor IX in 2018.

Segmentation based on end users

On the basis of end users, the hospital segment dominated the market with a market share of ~82% in 2018. This is due to the increase in the number of hospitals in developing countries and the rise in awareness of diseases like hemophilia. It is followed by clinics with a market share of 14.1% in 2018. The clinics market is driven by the growing number of clinics, increase in awareness among patients regarding plasma products and rise in the number of patients with blood and immunological disorders. Other end users that include research institutes, blood transfusion centers, and academic institutes was having the least market share in 2018.

Regional insights

North America is leading the blood plasma products market and occupied approximately 44.2% of the market in 2018. This is due to the rising incidence of haemophilia, and rapid approval by the FDA for the plasma products. Europe is likely to expand over the forecast period of 2018-2023, by exhibiting a CAGR of 6.6%. This is due to easy access to high-quality plasma through the contributions of qualified donors. Europe is followed by the Asia pacific with a market share of 19.3% in 2018. India and China are the major contributors of plasma products market in the Asia-Pacific region due to a large number of immunodeficient patients to get treated in hospitals and clinics. The Latin America and the Middle-East and Africa markets though, still at nascent stages, will also experience high growth because of the growing prevalence of blood disorders.

Companies covered
• CSL Behring
• Shire Plc
• Grifols S.A.
• Octapharma AG
• ADMA Biologics
• Kedrion Biopharma

Key Insights:
• The Medical solution providers, including names like CSL Behring, Shire Plc, and ADMA Biologics, led the charts with the highest number of Blood Plasma Products-based acquisitions.
• Emerging companies took a lead role in solving the problem of RF spectrum interference.

Avail Discount Offer@ https://www.worldwidemarketreports.com/discount/273936

Key questions addressed in the report:
• How innovative Blood Plasma Products solutions are making an impact in the Medical value chBlood Plasma Productsn?
• What are the challenges and issues addressed by the implementation of Blood Plasma Products algorithms in the Medical industry?
• What are the emerging use cases and business models that are driving the adoption of Blood Plasma Products?
• Who are the key enablers for Blood Plasma Products technology in the industry?
• Who are the frontrunners, and what are their implementations strategies?
• What is the current industry adoption status of Blood Plasma Products in Medical?
• Which are the disruptive entities that can be potential targets for driving Blood Plasma Products in Medical?
• Since 2014, what are the acquisition trends for Blood Plasma Products in Medical?
• What are opportunities for the Medical companies to build a strong roadmap for the future of autonomous networks?
• How can companies from other sectors tap into the Blood Plasma Products in Medical market?

Mr. Shah
Worldwide Market Reports
1001 4th Ave,
#3200 Seattle,
WA 98154
Tel: +1 415 871 0703
Email: sales@worldwidemarketreports.com

About Us:
Worldwide Market Reports is your one-stop repository of detailed and in-depth market research reports compiled by an extensive list of publishers from across the globe. We offer reports across virtually all domains and an exhaustive list of sub-domains under the sun. The in-depth market analysis by some of the most vastly experienced analysts provide our diverse range of clients from across all industries with vital decision making insights to plan and align their market strategies in line with current market trends. Worldwide Market Research’s well-researched inputs that encompass domains ranging from IT to healthcare enable our prized clients to capitalize upon key growth opportunities and shield against credible threats prevalent in the market in the current scenario and those expected in the near future.

This release was published on openPR.